Sectors
Norway-based Ultimovacs raised the funding through a share placement to investors including corporates Canica and Sundt.
Dow Chemical exited the diagnostic testing company, which had raised $24m in total, through the acquisition.
Johnson & Johnson and Takeda are among the investors committing $28m to fund graduates from the Israel-based programme.
Mitsui has a led the round that took the Qualcomm-backed clinical testing software company's overall funding to $38m.
The fitness equipment company has co-launched an accelerator that will target health and wellness technology startups.
The life sciences fund, which spun out from Elan Corporation, has reached a $98.5m first close for its second fund, securing investment from an undisclosed strategic.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
